Detection of coxsackie virus B and measurement level of Tumor necrosis factor alpha in patients suffered in T1DM with coxsackie virus infection

https://doi.org/10.53730/ijhs.v6nS5.11167

Authors

  • Meraj Nadhom Rafiq B.Sc., student, Department of, Pathological Analysis, College of Health and Medical Techniques /Kufa, Al-Furat Al-Awsat Technical University, Iraq
  • Humam Kasem Hussein Technical Institute of Najaf/ Al-Furat Al-Awsat Technical University, 31003 Al-Kufa, Iraq

Keywords:

Viral diseases, T1DM, TNF-α, Coxsackie virus

Abstract

Objective. Infection with Coxsackie virus. This virus that damages pancreatic cells, has long been linked to the onset of insulin-dependent diabetic mellitus (IDDM). Pro-inflammatory cytokines can be produced as a result of this illness. Tumor necrosis factor-a is one of these pro-inflammatory cytokines. Materials and Methods. Blood sample were collected from 180 Iraqi participants. Ninety of them is type 1 diabetic patients and other 90 is healthy control .both groups were tested for the incidence of Coxsackie virus B IgG. So the patients groups is divided to two groups according to sero positivity of CVB-IgG .all 180 patients tested to measure of level of TNF-α. Results. The Results showed increasing in levels of TNF-α in CBV positive Type 1 Diabetes mellitus was (34.85 ± 11.00 pg/ml). The level of this interleukin in Type 1 Diabetes mellitus negative to that virus was (26.16 ± 7.79 pg/ml). While the results of this interleukin in control group was (13.82 ± 3.93 pg/ml) with p-value 0. Conclusion. The concentration of TNF-α, according to results, has been shown to be associated with type 1 diabetes mellitus patients infected with CVB-IgG and diabetic patients without CVB.

Downloads

Download data is not yet available.

References

Alam, S.; Hasan, M.; Neaz, S.; Hussain, N.; Hossain, M. and Rahman, T. (2021). Diabetes Mellitus: insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetology, 2(2), 36-50.‏

Alberts, B.; Johnson, A.; Lewis, J.; Raff, M.; Roberts, K. and Walter, P. (2002). The Adaptive Immune System, Chapter 24. In: Molecular Biology of the Cell, 4th ed. New York: Garland Science.

Alidjinou E. K.; Sane, F.; Engelmann, I. and Hober D. (2013). Serum-dependent enhancement of coxsackievirus B4-induced production of IFNalpha, IL-6 and TNFalpha by peripheral blood mononuclear cells. J Mol Biol. 425:5020–31. doi: 10.1016/j.jmb.2013.10.008

Ariwibowo, M. F., Wahab, Z., Isnanta, R., & Isnurhadi, I. (2020). Physical evidence promotion on consumer decisions in using bowling sport services. International Journal of Social Sciences and Humanities, 4(3), 22–28. https://doi.org/10.29332/ijssh.v4n3.445

Bergamin, C. S.; Pérez-Hurtado, E.; Oliveira, L.; Gabbay, M.; Piveta, V.; Bittencourt, C. and Dib, S. A. (2020). Enterovirus Neutralizing Antibodies, Monocyte Toll Like Receptors Expression and Interleukin Profiles Are Similar Between Non-affected and Affected Siblings From Long-Term Discordant Type 1 Diabetes Multiplex-Sib Families: The Importance of HLA Background. Frontiers in Endocrinology, 662.‏

Cooling, L. (2015). Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev. 28(3): 801-870.

Corrales-Aguilar, E.; Trilling, M.; Reinhard, H.; Falcone, V.; Zimmermann, A.; Adams, O.; Hengel, H. et al. (2016). Highly individual patterns of virus-immune IgG effector responses in humans. Medical microbiology and immunology, 205(5): 409-424.

De Beeck, A. O. and Eizirik, D. L. (2016). Viral infections in type 1 diabetes mellitus—why the β cells?. Nature Reviews Endocrinology, 12(5), 263-273.‏

Gomez-Díaz, R. A. (2019). Pathophysiology of Type 1 Diabetes. In: The Diabetes Textbook, 89-99. Cham: Springer

Hussein. H. K. (2019). Detection the infection with viral hepatitis C in Suwayrah/Wasit Governorate /Iraq. Journal of Global Pharma Technology, 251-255

Kahaly, G. J. and Hansen, M. P. (2016). Type 1 diabetes associated autoimmunity. Autoimmunity reviews, 15(7): 644-648.

Lien, E., and Zipris, D. (2009). The role of Toll-like receptor pathways in the mechanism of type 1 diabetes. Current molecular medicine, 9(1), 52-68.‏

Lu, J.; Liu, J.; Li, L.; Lan, Y. and Liang, Y. (2020). Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targets. Clinical & translational immunology, 9(3), e1122

Masriadi, M., Mahmud, N. U., Muriyati, M., Adam, R. K., Alawiyah, T., Safruddin, S., Amir, H., & Asnidar, A. (2022). Determinant of metabolic syndrome: Case study hypertension and diabetes mellitus type II. International Journal of Health Sciences, 6(2), 1046–1057. https://doi.org/10.53730/ijhs.v6n2.10800

Ramos-Morcillo, A.; Moreno-Martínez, F.; Hernández Susarte, A.; Hueso-Montoro, C. and Ruzafa-Martínez, M. (2019). Social Determinants of Health, the Family, and Children’s Personal Hygiene: A Comparative Study. International journal of environmental research and public health, 16(23): 4713.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864

Published

27-07-2022

How to Cite

Rafiq, M. N., & Hussein, H. K. (2022). Detection of coxsackie virus B and measurement level of Tumor necrosis factor alpha in patients suffered in T1DM with coxsackie virus infection. International Journal of Health Sciences, 6(S5), 11565–11571. https://doi.org/10.53730/ijhs.v6nS5.11167

Issue

Section

Peer Review Articles